ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma.
作者信息
Konishi Takanori, Takano Shigetsugu, Ohtsuka Masayuki
机构信息
Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
出版信息
Ann Surg Oncol. 2024 Oct;31(10):7074-7075. doi: 10.1245/s10434-024-15853-1. Epub 2024 Jul 17.
Abstract
摘要
相似文献
1
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma.
Ann Surg Oncol. 2024 Oct;31(10):7074-7075. doi: 10.1245/s10434-024-15853-1. Epub 2024 Jul 17.
2
ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma.
Ann Surg Oncol. 2024 Sep;31(9):6199-6200. doi: 10.1245/s10434-024-15391-w. Epub 2024 May 20.
3
Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis.
J Surg Oncol. 2020 Nov;122(6):1074-1083. doi: 10.1002/jso.26103. Epub 2020 Jul 16.
4
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease.
Ann Surg Oncol. 2024 Jun;31(6):4115-4116. doi: 10.1245/s10434-024-15175-2. Epub 2024 Mar 12.
5
ASO Author Reflections: Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma and Operative Margin Revision.
Ann Surg Oncol. 2024 Sep;31(9):6197-6198. doi: 10.1245/s10434-024-15658-2. Epub 2024 Jun 21.
6
Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.
Surgery. 2017 Jun;161(6):1579-1587. doi: 10.1016/j.surg.2016.12.038. Epub 2017 Feb 23.
7
Treatment strategy of intraductal papillary-mucinous tumor of the pancreas.
J Gastroenterol. 2005 Jul;40(7):773-4. doi: 10.1007/s00535-005-1648-2.
8
A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Acta Gastroenterol Belg. 2017 Oct-Dec;80(4):451-461.
9
Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
Surgery. 2017 Feb;161(2):373-384. doi: 10.1016/j.surg.2016.08.005. Epub 2016 Nov 9.
10
Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
J Hepatobiliary Pancreat Sci. 2016 Aug;23(8):472-9. doi: 10.1002/jhbp.365. Epub 2016 Jul 15.
本文引用的文献
1
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
Lancet Gastroenterol Hepatol. 2024 Mar;9(3):205-217. doi: 10.1016/S2468-1253(23)00405-3. Epub 2024 Jan 15.
2
Role of neoadjuvant treatment in resectable pancreatic cancer according to vessel invasion and increase of CA19-9 levels.
J Hepatobiliary Pancreat Sci. 2023 Jul;30(7):924-934. doi: 10.1002/jhbp.1302. Epub 2023 Mar 13.
3
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27.
Zotero 插件